Mass-Producing a Crab-Derived Antimicrobial Peptide That Kills Foodborne Bacteria
A marine antimicrobial peptide from mud crab was produced at high yield (126.1 mg/L) using engineered yeast, showing potent activity against foodborne pathogens with no toxicity to human cells.
Quick Facts
What This Study Found
Researchers achieved high-yield production of the marine antimicrobial peptide Spgillcin177-189 using a multicopy yeast expression system in Pichia pastoris. The multicopy strategy yielded 126.1 mg/L — 2.75 times more than single-copy strains. The recombinant peptide showed potent activity against multiple foodborne pathogens (MIC range 5.25–84 μg/mL), effective bactericidal and anti-biofilm activity against S. aureus and V. parahaemolyticus, good heat stability, and no significant cytotoxicity or hemolysis.
The peptide works by targeting bacterial cell membranes via hydrogen bonding with surface components, disrupting membrane integrity and causing cell death.
Key Numbers
126.1 mg/L yield · 2.75× improvement over single-copy · MIC 5.25–84 μg/mL · active against S. aureus and V. parahaemolyticus · no cytotoxicity or hemolysis
How They Did This
Established a Pichia pastoris yeast expression system for recombinant Spgillcin177-189 production. Used Golden Gate assembly technology to construct multicopy plasmids for enhanced expression. Tested antibacterial activity (MIC), bactericidal activity, anti-biofilm activity, thermostability, cytotoxicity, and hemolytic activity. Investigated the mechanism of bacterial membrane disruption.
Why This Research Matters
Antibiotic resistance in foodborne bacteria and consumer demand for chemical-free food preservation are creating urgent need for natural antimicrobial alternatives. This study solves a key manufacturing bottleneck — producing enough antimicrobial peptide affordably — which is essential for any real-world food safety application.
The Bigger Picture
The food industry needs alternatives to chemical preservatives and antibiotics as resistance grows and consumers demand cleaner labels. Antimicrobial peptides are promising but have been held back by high production costs. This multicopy yeast expression strategy addresses the manufacturing problem directly, bringing AMP-based food preservation closer to commercial viability.
What This Study Doesn't Tell Us
This is an in vitro production and characterization study. The peptide has not been tested in actual food preservation applications or in vivo. Scale-up from laboratory to industrial production remains to be demonstrated. Activity against a limited panel of foodborne pathogens was tested.
Questions This Raises
- ?Can this production system scale to industrial volumes while maintaining the peptide's antimicrobial potency?
- ?How does Spgillcin177-189 perform when applied to actual food products rather than bacterial cultures in the lab?
- ?Could this multicopy expression strategy be adapted for other antimicrobial peptides that face the same production bottleneck?
Trust & Context
- Key Stat:
- 126.1 mg/L — a 2.75× production boost Using multicopy gene engineering in yeast, researchers nearly tripled the production of a marine antimicrobial peptide, addressing the key manufacturing barrier to using natural peptides in food preservation.
- Evidence Grade:
- Rated preliminary because this is an in vitro production and characterization study. While the engineering and antimicrobial results are promising, the peptide has not been tested in food applications or in vivo.
- Study Age:
- Published in 2025 in Probiotics and Antimicrobial Proteins. This is very recent work addressing the active challenge of scalable antimicrobial peptide manufacturing.
- Original Title:
- Multicopy Expression of the Marine Antimicrobial Peptide Spgillcin177-189 in Pichia pastoris for High-Yield Production and Potent Activity Against Foodborne Pathogens.
- Published In:
- Probiotics and antimicrobial proteins (2025)
- Authors:
- Dong, Xianxian, Liao, Huiliang, Zhang, Chang(2), Chen, Fangyi, Peng, Hui, Hong, Xiao, Hao, Hua, Xiong, Ming, Ma, Jiahao, Wang, Ke-Jian
- Database ID:
- RPEP-10759
Evidence Hierarchy
Frequently Asked Questions
Where does this antimicrobial peptide come from?
Spgillcin177-189 was originally discovered in the mud crab Scylla paramamosain. Rather than extracting it from crabs, the researchers engineered baker's yeast (Pichia pastoris) to produce it in large quantities using recombinant DNA technology.
Could this peptide replace antibiotics in food production?
That's the goal. The peptide kills foodborne bacteria like Staph aureus at low concentrations, resists heat, and doesn't harm human cells. But it still needs to be tested in actual food products and scaled to industrial production before it could replace chemical preservatives or antibiotics.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10759APA
Dong, Xianxian; Liao, Huiliang; Zhang, Chang; Chen, Fangyi; Peng, Hui; Hong, Xiao; Hao, Hua; Xiong, Ming; Ma, Jiahao; Wang, Ke-Jian. (2025). Multicopy Expression of the Marine Antimicrobial Peptide Spgillcin177-189 in Pichia pastoris for High-Yield Production and Potent Activity Against Foodborne Pathogens.. Probiotics and antimicrobial proteins. https://doi.org/10.1007/s12602-025-10874-y
MLA
Dong, Xianxian, et al. "Multicopy Expression of the Marine Antimicrobial Peptide Spgillcin177-189 in Pichia pastoris for High-Yield Production and Potent Activity Against Foodborne Pathogens.." Probiotics and antimicrobial proteins, 2025. https://doi.org/10.1007/s12602-025-10874-y
RethinkPeptides
RethinkPeptides Research Database. "Multicopy Expression of the Marine Antimicrobial Peptide Spg..." RPEP-10759. Retrieved from https://rethinkpeptides.com/research/dong-2025-multicopy-expression-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.